Choline Supplementation Protects against Liver Damage by Normalizing Cholesterol Metabolism in Pemt/Ldlr Knockout Mice Fed a High-Fat Diet. Issue 3 (24th December 2013)

• Record Type: Journal Article
• Authors: Al Rajabi, Ala; Castro, Gabriela S. F.; da Silva, Robin P.; Nelson, Randy C.; Thiesen, Aducio; Vannucchi, Helio; Vine, Donna F.; Proctor, Spencer D.; Field, Catherine J.; Curtis, Jonathan M.; Jacobs, René L.
• Is Part Of: Journal of nutrition. Volume 144:Issue 3(2014)
• Page Start: 252
• Page End: 257
• Publication Date: 2013-12-24
• Subjects: Nutrition -- Periodicals; Diet -- Periodicals; 613.205
• DOI: 10.3945/jn.113.185389
• Languages: English
• ISSNs: 0022-3166

Abstract

Abstract: Dietary choline is required for proper structure and dynamics of cell membranes, lipoprotein synthesis, and methyl-group metabolism. In mammals, choline is synthesized via phosphatidylethanolamine N -methyltransferase ( Pemt ), which converts phosphatidylethanolamine to phosphatidylcholine. Pemt −/− mice have impaired VLDL secretion and developed fatty liver when fed a high-fat (HF) diet. Because of the reduction in plasma lipids, Pemt −/− / low-density lipoprotein receptor knockout ( Ldlr −/− ) mice are protected from atherosclerosis. The goal of this study was to investigate the importance of dietary choline in the metabolic phenotype of Pemt −/− /Ldlr −/− male mice. At 10–12 wk of age, Pemt +/+ /Ldlr −/− (HF +/+ ) and half of the Pemt −/− /Ldlr −/− (HF −/− ) mice were fed an HF diet with normal (1.3 g/kg) choline. The remaining Pemt −/− /Ldlr −/− mice were fed an HF diet supplemented (5 g/kg) with choline (HFCS −/− mice). The HF diet contained 60% of calories from fat and 1% cholesterol, and the mice were fed for 16 d. HF −/− mice lost weight and developed hepatomegaly, steatohepatitis, and liver damage. Hepatic concentrations of free cholesterol, cholesterol-esters, and triglyceride (TG) were elevated by 30%, 1.1-fold and 3.1-fold, respectively, in HF −/− compared with HF +/+ mice. Choline supplementation normalized hepatic cholesterol, but not TG, and dramatically improved liver function. The expression of genes involved in cholesterol transport and esterification increased by 50% to 5.6-fold in HF −/− mice when compared with HF +/+ mice. Markers of macrophages, oxidative stress, and fibrosis were elevated in the HF −/− mice. Choline supplementation normalized the expression of these genes. In conclusion, HF −/− mice develop liver failure associated with altered cholesterol metabolism when fed an HF/normal choline diet. Choline supplementation normalized cholesterol metabolism, which was sufficient to prevent nonalcoholic steatohepatitis development and improve liver function. Our data suggest that choline can promote liver health by maintaining cholesterol homeostasis.